Norditropin®
somatropin (rDNA origin) injection
| Manufacturer: NovoNordisk |
|
| |
|
Indications: Norditropin® is a recombinant human growth hormone indicated
for:
• Pediatric: Treatment of children with growth failure due to
growth hormone deficiency (GHD), short stature associated
with Noonan syndrome, short stature associated with Turner
syndrome and short stature born SGA with no catch-up growth
by age 2–4 years (1.1)
• Adult: Treatment of adults with either adult onset or childhood
onset GHD (1.2) |
|
| |
|
| |
|
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
|
Novonordisk |
Norditropin® Cartridges |
5 mg/ 1.5 mL |
00169-7768-11 |
PI |
MSDS |
|
|
|
15 mg/ 1.5 mL |
00169-7770-11 |
PI |
MSDS |
|
|
Norditropin® Nordiflex®
prefilled pens |
5 mg/ 1.5 mL |
00169-7704-11 |
PI |
MSDS |
|
|
|
10 mg/ 1.5 mL |
00169-7705-11 |
PI |
MSDS |
|
|
|
15 mg/ 1.5 mL |
00169-7708-11 |
PI |
MSDS |
|
|
| |
|
| |
|
|
| |
| Additional information about Norditropin®, and many
other products may be found in our
Clinical Resources
section. If you need additional information regarding any of these
products please
contact BDI
Pharma or call 1-
800-948-9834. |
| |
|
|